Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.
about
Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly.Prospective study of surgical treatment of acromegaly: effects on ghrelin, weight, adiposity, and markers of CV riskPitfalls in the diagnosis of acromegaly.The challenges of reliance on insulin-like growth factor I in monitoring disease activity in patients with acromegaly.Recent developments in the therapy of acromegaly.Dynamic tests and basal values for defining active acromegaly.Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant?No differences in metabolic outcomes between nadir GH 0.4 and 1.0 ng/mL during OGTT in surgically cured acromegalic patients (observational study).Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LAR.Emerging trends in the diagnosis and treatment of acromegaly in Canada.The value of an acute octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly.Growth hormone after oral glucose overload: revision of reference values in normal subjects.Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment.Long-term changes in serum IGF-1 levels after successful surgical treatment of growth hormone-secreting pituitary adenoma.Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients.The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism.Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL)
P2860
Q31139308-C91BF018-DB40-4E7C-8344-37F83238FAD4Q34468089-B0396440-9973-4E42-BA54-25DD635DAFD3Q35946611-ABC13FB7-A64F-4C18-9DEE-9CDC08A0982DQ36068074-3B6C6FB1-49E6-4F4D-B34C-50335A9A0ADEQ36407309-C02957B7-2836-4067-AC71-F12349C0900CQ36626485-EBDFBD3E-2448-4B20-B07C-80A5C1D54B54Q36626503-92D16FB0-C11D-40DD-AFAF-FDB21A55FE21Q36845980-3EB61855-FC83-487A-9972-71C13081F7F9Q37205596-6BD54511-0FF5-4930-9A14-DFB8214D8985Q38912799-C956CF09-0095-46EF-9222-97D5854145F1Q44658146-F5423A49-96F8-4BEC-93B2-472A92ACC0BFQ45282212-927E7C38-719B-4C1C-82DA-C8F8E2C3F68AQ46198507-B2D5FFFD-DA66-4DAE-8383-E84DE65FA74BQ50884057-7ED9A4C5-0038-49C3-BB47-EF2A939F1203Q50944176-852C87FD-4715-448B-9AE8-6820FA5E7202Q51344066-FBAC80DF-AF4E-4C54-AB9F-C00CB1B48E33Q51374449-B0806B9B-0410-427D-9C2C-D1D046C610CBQ51384443-381D8D23-479A-4AA2-AA6C-046DAD7279B1Q57217677-93C282D5-3289-4284-89C4-0AE450620FEF
P2860
Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Long-term biochemical status a ...... tive patients with acromegaly.
@en
Long-term biochemical status a ...... tive patients with acromegaly.
@nl
type
label
Long-term biochemical status a ...... tive patients with acromegaly.
@en
Long-term biochemical status a ...... tive patients with acromegaly.
@nl
prefLabel
Long-term biochemical status a ...... tive patients with acromegaly.
@en
Long-term biochemical status a ...... tive patients with acromegaly.
@nl
P2093
P356
P1476
Long-term biochemical status a ...... tive patients with acromegaly.
@en
P2093
Catherine Beauregard
Jules Hardy
Omar Serri
P304
P356
10.1210/JC.2003-030915
P407
P577
2004-02-01T00:00:00Z